Chinese Medical Doctor Association

Advancing Healthcare Access: Genesis MedTech Teams Up with Silk Road Medical to Serve Patients affected by Carotid Artery Disease in China

Retrieved on: 
Freitag, März 8, 2024
Chinese Medical Doctor Association, Stroke, Neck, CEA, Physician, Common carotid artery, Carotid artery stenosis, Plaque, Risk, Splenic infarction, Genesis, Disability, Death, CNI, Cranial nerves, Health, Patient, Atherosclerosis, TCAR, Stenosis, Mortality, Medtech, SILK, Brain, Pharmaceutical industry

TCAR (Transcarotid Artery Revascularization) is an innovative minimally invasive surgical procedure used to treat carotid artery disease, a condition characterized by the narrowing or blockage of the carotid arteries in the neck.

Key Points: 
  • TCAR (Transcarotid Artery Revascularization) is an innovative minimally invasive surgical procedure used to treat carotid artery disease, a condition characterized by the narrowing or blockage of the carotid arteries in the neck.
  • Since its establishment in 2019, Genesis MedTech Group has continuously strived to enhance its peripheral interventional portfolio, offering comprehensive solutions to both physicians and patients.
  • Before the introduction of TCAR, moderate to severe carotid artery disease was generally treated clinically with two surgical methods: Carotid Endarterectomy (CEA) and Transfemoral Carotid Artery Stenting (TFCAS).
  • Together with Silk Road Medical, we remain dedicated to make better healthcare more accessible, improving patient care and outcomes."

S'Young International Showcases Cross-Cultural Beauty Solutions at its First Luxury Hair Care Grand Ceremony

Retrieved on: 
Donnerstag, September 7, 2023
Hair, Laboratory, Chinese Medical Doctor Association, Atmosphere, Hair loss, Physician, Dermatology, Light, Research, Attention, Beauty, New media art, City, Environment, RMB, Retail, Cosmetics

This ceremony is held in Changsha, which has been continuously rated as one of the happiest cities in China for fifteen consecutive years.

Key Points: 
  • This ceremony is held in Changsha, which has been continuously rated as one of the happiest cities in China for fifteen consecutive years.
  • Additionally, as one of the most representative new Tier 1 cities, Changsha embraces China's youngest, most contemporary, and most diverse consumer groups.
  • The first S'Young Luxury Hair Care Brand Ceremony aimed to bring together global brands beyond geographical, cultural, and product limitations.
  • Representing the epitome of "Fashionable Hair Care," Björn Axén, hailing from Sweden, took the attendees on a journey into the world of hair aesthetics with a presentation that delves into the brand's craftsmanship and high-end hair care solutions.

S'Young International Showcases Cross-Cultural Beauty Solutions at its First Luxury Hair Care Grand Ceremony

Retrieved on: 
Donnerstag, September 7, 2023
Hair, Laboratory, Chinese Medical Doctor Association, Atmosphere, Hair loss, Physician, Dermatology, Light, Research, Multimedia, Attention, Beauty, New media art, City, Environment, RMB, Retail, Cosmetics

This ceremony is held in Changsha, which has been continuously rated as one of the happiest cities in China for fifteen consecutive years.

Key Points: 
  • This ceremony is held in Changsha, which has been continuously rated as one of the happiest cities in China for fifteen consecutive years.
  • Additionally, as one of the most representative new Tier 1 cities, Changsha embraces China's youngest, most contemporary, and most diverse consumer groups.
  • The first S'Young Luxury Hair Care Brand Ceremony aimed to bring together global brands beyond geographical, cultural, and product limitations.
  • Representing the epitome of "Fashionable Hair Care," Björn Axén, hailing from Sweden, took the attendees on a journey into the world of hair aesthetics with a presentation that delves into the brand's craftsmanship and high-end hair care solutions.

YSG's first participation at WCD, with two major brands

Retrieved on: 
Freitag, Juli 28, 2023
Cream, Molecule, International League, Exhibition, Chinese Medical Doctor Association, YSG, University, Gregory Mandel, Acne, Medicine, Research, History, Element, Snow, Multimedia, Trial of the century, Congress, Hospital, Beauty, Galenic, Patent, Laboratory, Couture, The International League of Dermatological Societies, Growth, Diagnosis, Innovation, SCI, VC, Human, ILDS, Skin, Safety, Pharmaceutical industry, Management, Fine chemical, Medical device, Entertainment, Seaweed, Dermatology, WCD

The innovative ideas of beauty technology have been approached and approved by many dermatologists and professors from all over the world.

Key Points: 
  • The innovative ideas of beauty technology have been approached and approved by many dermatologists and professors from all over the world.
  • In 2022, the Company upgraded its annual R&D expense ratio to 3.4%, which continued to be in the front rank globally.
  • YSG's participation in WCD will be an important step in the layout of its global R&D system.
  • While exhibiting its remarkable dual clinical study at the WCD, it is also celebrating the brand's 20th anniversary in Singapore.

BreathMo®: The New Generation ECMO system Revealed at ASAIO Conference

Retrieved on: 
Samstag, Juli 22, 2023
Heart, Revolution, Hospice and palliative medicine, Embolism, American Society for Artificial Internal Organs, SSS, Hemolysis, Extracorporeal membrane oxygenation, Chinese Medical Doctor Association, ASAIO, COVID-19, Health status of Asian Americans, ECMO, WSS, VV, Sheep, VWF, Patient, Article, Risk, Engineering, Blood, Annual general meeting, End organ damage, Mortality, ICU, Hospital, Device, MCS, Society, CFD, Autopsy, Safety, Medical device, Science, Medicine

Extracorporeal Membrane Oxygenation (ECMO) provides essential support for intensive care unit (ICU) patients, 60% of whom develop heart or respiratory failure with a mortality rate of 23-75%.

Key Points: 
  • Extracorporeal Membrane Oxygenation (ECMO) provides essential support for intensive care unit (ICU) patients, 60% of whom develop heart or respiratory failure with a mortality rate of 23-75%.
  • The limitation of the existing ECMO systems exposed the need for medical device manufacturers to upgrade ECMO devices equipped with advanced functions.
  • BreathMo®, China's homegrown maglev ECMO system that addresses the unmet medical needs of Chinese patients.
  • To bridge clinical gaps in China, magAssist has developed a new generation ECMO system, BreathMo®.

BreathMo®: The New Generation ECMO system Revealed at ASAIO Conference

Retrieved on: 
Freitag, Juli 21, 2023
Heart, Revolution, Hospice and palliative medicine, Embolism, American Society for Artificial Internal Organs, SSS, Hemolysis, Extracorporeal membrane oxygenation, Chinese Medical Doctor Association, ASAIO, COVID-19, Health status of Asian Americans, ECMO, WSS, VV, Sheep, VWF, Patient, Article, Risk, Engineering, Blood, Annual general meeting, End organ damage, Mortality, ICU, Hospital, Device, MCS, Society, CFD, Autopsy, Safety, Medical device, Science, Medicine

Extracorporeal Membrane Oxygenation (ECMO) provides essential support for intensive care unit (ICU) patients, 60% of whom develop heart or respiratory failure with a mortality rate of 23-75%.

Key Points: 
  • Extracorporeal Membrane Oxygenation (ECMO) provides essential support for intensive care unit (ICU) patients, 60% of whom develop heart or respiratory failure with a mortality rate of 23-75%.
  • The limitation of the existing ECMO systems exposed the need for medical device manufacturers to upgrade ECMO devices equipped with advanced functions.
  • BreathMo®, China's homegrown maglev ECMO system that addresses the unmet medical needs of Chinese patients.
  • To bridge clinical gaps in China, magAssist has developed a new generation ECMO system, BreathMo®.

Impulse Dynamics Announces 100th Implant Milestone in China for CCM® Therapy

Retrieved on: 
Mittwoch, November 16, 2022
Tao, Marketing, Blood, Cardiac muscle, Heart, Muscle tissue, Medicine, Forward problem of electrocardiology, Heart rate, Chinese Academy of Medical Sciences COVID-19 vaccine, Safety, Physician, Patient, Heart failure, National Center for Health Research, Chinese Medical Doctor Association, MD, Mathematical optimization, CCM, News, Internal medicine, Chinese Academy of Fishery Sciences, Death, Degenerative disease, Research, Quality of life, Hope, Medicine in China, FDA, Medical device, Pharmaceutical industry

It is quite a coincidental milestone for us that the 10th patient implanted in our center also happened to be the 100th patient treated in China.

Key Points: 
  • It is quite a coincidental milestone for us that the 10th patient implanted in our center also happened to be the 100th patient treated in China.
  • I have paid very close attention to CCM therapy for more than 20 years now, but it wasnt until recently we could clinically apply this technology.
  • All the CCM patients in our center improved both symptomatically and on various objective indicators, which made both us and our patients very happy.
  • CCM therapy was approved in China late last year, and the first implant in the country was announced on November 1, 2021.

SPO Global Inc. Provides Update on Shandong SPO Medical (Group) Co., Ltd.

Retrieved on: 
Donnerstag, März 10, 2022
Twitter, Private Securities Litigation Reform Act, OTC, Biomedicine, ERCP, Company, U.S. Securities and Exchange Commission, Education, Health, Chinese Medical Doctor Association, Safe harbor, Shandong University, OTC Markets Group, Acquisition, Hospital (district), Hospital, Forward-looking statement, GLOBE, Bed, Patient, Rehabilitation, Security (finance), The Third Hospital, Stroke, Technology, State Security Law in Bahrain, Growth, Goal, Federal, Health insurance

The introduction of the project will effectively solve the problems of difficult, expensive and inconvenient medical treatment in local communities.

Key Points: 
  • The introduction of the project will effectively solve the problems of difficult, expensive and inconvenient medical treatment in local communities.
  • The third provincial hospital affiliated to Shandong University is Shandong Provincial Health Committee .
  • The third-class A-level general hospital directly under it is a medical group that integrates medical treatment, teaching, scientific research, preventive health care and rehabilitation.
  • We encourage our shareholders to visit our corporate Twitter account for more updates: https://twitter.com/spo_global
    About SPO Global Inc. (OTC Pink: SPOM): SPO Global Inc. recently completed its merger with Gerpang Healthcare Group.

Zhongchao Inc. Launches Hematology MDT Training Platform to Improve Diagnosis and Treatment

Retrieved on: 
Freitag, September 17, 2021
People, WebRTC, Degenerative disease, Wu Zhongchao, Efficiency, Technology, Hematology, Forward-looking statement, MDT, Coronavirus, First Affiliated Hospital of Xinjiang Medical University, Patient, Company, Private Securities Litigation Reform Act, Microbiology, Second Affiliated Hospital of Xinjiang Medical University, Disease, Human, Physician, Infection, Medicine in China, Hospital, NASDAQ, Solution, Growth, Chinese Medical Doctor Association, Neoplasm, Review, Learning, Lists of diseases, Guangzhou Medical University, Diagnosis, Goal, SEC, Cancer, 301 Hospital, Chongqing Medical University, Ruijin Hospital, Medicine, Public relations

SHANGHAI, Sept. 17, 2021 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), aninternet technology company offering healthcare professionals the online healthcare information, professional training and educational services platform and patients the patient management platform, today announced the launch of its multidisciplinary treatment ("MDT") clinical thinking training platform for hematology ("Hematology MDT Platform").

Key Points: 
  • SHANGHAI, Sept. 17, 2021 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), aninternet technology company offering healthcare professionals the online healthcare information, professional training and educational services platform and patients the patient management platform, today announced the launch of its multidisciplinary treatment ("MDT") clinical thinking training platform for hematology ("Hematology MDT Platform").
  • The Hematology MDT Platform provides clinicians with a channel to learn multidisciplinary thinking skills online, in order to improve diagnosis and treatment and further the efficiency of treatment.
  • In addition, physicians can watch MDT training videos to learn the clinical thinking skills from experts and improve their problem-solving ability during the disease diagnosis and treatment.
  • Zhongchao's Hematology MDT platform provides physicians with a convenient and rapid access to learn and exchange MDT practices and experiences andwill promote the development of hematology treatment models in China.